This content originally appeared on Reuters and was authored by Reuters
This content originally appeared on Reuters and was authored by Reuters
Print
Share
Comment
Cite
Upload
Translate
Updates
There are no updates yet.
Click the Upload button above to add an update.
APA
MLA
Reuters | Sciencx (2021-06-07T20:33:22+00:00) Breakthrough or risk? FDA approves Alzheimer’s drug. Retrieved from https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/
" » Breakthrough or risk? FDA approves Alzheimer’s drug." Reuters | Sciencx - Monday June 7, 2021, https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/
HARVARDReuters | Sciencx Monday June 7, 2021 » Breakthrough or risk? FDA approves Alzheimer’s drug., viewed ,<https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/>
VANCOUVERReuters | Sciencx - » Breakthrough or risk? FDA approves Alzheimer’s drug. [Internet]. [Accessed ]. Available from: https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/
CHICAGO" » Breakthrough or risk? FDA approves Alzheimer’s drug." Reuters | Sciencx - Accessed . https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/
IEEE" » Breakthrough or risk? FDA approves Alzheimer’s drug." Reuters | Sciencx [Online]. Available: https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/. [Accessed: ]
rf:citation » Breakthrough or risk? FDA approves Alzheimer’s drug | Reuters | Sciencx | https://www.scien.cx/2021/06/07/breakthrough-or-risk-fda-approves-alzheimers-drug/ |
Please log in to upload a file.
There are no updates yet.
Click the Upload button above to add an update.